Clinical Trials Directory

Trials / Completed

CompletedNCT03679663

Ultrasound Versus Palpation for Spinal Anesthesia Success

Prospective Randomized Controlled Trial to Compare a Handheld Ultrasound Identification of the Neuraxial Block Insertion Site Versus Palpation Only in an Obese Population of Women Undergoing Cesarean Delivery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Tel-Aviv Sourasky Medical Center · Other Government
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Aim is to investigate the difference in number of attempts to place neuraxial block comparing handheld ultrasound versus use of palpation alone for women with impalpable bony landmarks undergoing spinal anesthesia for elective cesarean delivery.

Detailed description

Patients will be recruited prior to cesarean delivery and their site of lumbar injection will be examined. Women with impalpable bony landmarks will be offered recruitment to the study. Women will be randomly assigned to the standard of care group - palpation attempts only, versus an ultrasound group, where the insertion point will be identified by the handheld ultrasound device Inclusion criteria: Lumbar spinous processes impalpable. Elective cesarean delivery for singleton pregnancies BMI \>30 No contraindications to neuraxial block Signed informed consent Neuraxial Block planned Exclusion Criteria Refuses informed consent Poor written Hebrew, no spoken English or Hebrew Patients will be randomized into two groups : an ultrasound (US) group and a palpation (PP) group. The primary outcome of our study is the number of needle redirections, defined as any ventral advancement of the needle and/or introducer, as well as any new intervertebral space attempted. Secondary outcomes include: The insertion site identification time, patient verbal numerical pain score (0-10) after skin incision.

Conditions

Interventions

TypeNameDescription
DEVICEUltrasoundUse of ultrasound to identify pre-puncture site

Timeline

Start date
2018-12-20
Primary completion
2020-08-04
Completion
2020-08-04
First posted
2018-09-20
Last updated
2020-10-05

Locations

1 site across 1 country: Israel

Regulatory

Source: ClinicalTrials.gov record NCT03679663. Inclusion in this directory is not an endorsement.